Under the agreement, Thermo Fisher will acquire Sanofi's steriles manufacturing site in Ridgefield, New Jersey and will continue to manufacture a portfolio of therapies for Sanofi. In addition, Thermo Fisher will expand use of the site to meet the growing demand from pharma and biotech customers for U.S. manufacturing capacity.

The Ridgefield site is a state-of-the-art sterile fill-finish and packaging facility with a world-class team of more than 200 employees who will join Thermo Fisher following the completion of the transaction.

"Sanofi's Ridgefield site will strengthen our U.S. manufacturing capabilities, enabling us to better support our pharmaceutical and biotech customers with the critical production capacity needed for essential medicines," said Marc N. Casper, chairman, president and chief executive officer of Thermo Fisher. "We will also expand and further strengthen our long-standing partnership with Sanofi, while investing to bring additional capacity and enhanced capabilities at this site. We look forward to welcoming all Ridgefield employees to Thermo Fisher later this year."

Thermo Fisher operates a leading global sterile fill-finish manufacturing network, which currently includes U.S. sites in Greenville, North Carolina and Plainville, Massachusetts. These sites are integral to the company's Accelerator^TM Drug Development 360° CDMO and CRO solutions, transforming the pharmaceutical value chain for emerging biotech and biopharma companies to speed life-changing medicines to patients.

The transaction is expected to be completed in the second half of 2025, subject to customary closing conditions. Upon completion of the transaction, Sanofi's Ridgefield facility will become part of Thermo Fisher's pharma services business within its Laboratory Products and Biopharma Services segment.

In May 2023, Sanofi officially opened its new state-of-the-art office in downtown Morristown, New Jersey, bringing together nearly 2,000 employees in a collaborative, sustainable workspace. Sanofi CEO Paul Hudson, New Jersey Governor Phil Murphy, and Morristown Mayor Tim Dougherty led the ribbon-cutting ceremony alongside community leaders and Sanofi executives.

"Sanofi is an intrinsic part of the healthcare ecosystem of the United States, where we pioneer advancements in our labs, produce medicines and vaccines that improve people's lives, and grow our talented workforce," said CEO Paul Hudson. "Our people are our biggest asset and providing them with a cutting-edge workplace experience is key to help them thrive and do their best work. These flagship offices are designed to inspire creativity, collaboration and innovation - all in service of patients." Governor Murphy praised the facility as " a significant vote of confidence in New Jersey's thriving innovation economy."

The 260,000-square-foot facility represents Sanofi's vision for a science-driven, best-in-class workplace. Designed with sustainability at its core, the building will be LEED Gold Certified and uses 28% less energy than standard offices and reduces greenhouse gas emissions by over 24%.